In addition, overexpression of the channel in our patient samples suggests Kv1.3 is a novel therapeutic target to treat pancreas cancer, although the specific role of mitochondrial Kv1.3 in patients with PDAC has not been addressed here. Here, KCNA3 is linked to pancreatic neoplasm.